Cancer stem cell: target for anti-cancer therapy
- PMID: 17625071
- DOI: 10.1096/fj.07-8560rev
Cancer stem cell: target for anti-cancer therapy
Abstract
Cancer has long been viewed as a heterogeneous population of cells. While the great majority of cells that make up tumors are destined to differentiate, albeit aberrantly, and eventually stop dividing, only a minority population of cells, termed cancer stem cells, possess extensive self-renewal capability and can recapitulate tumor pathophysiology in an immune-compromised animal model. Tumor-initiating cells have been identified and isolated in a variety of cancers of the blood, breast, central nervous system, pancreas, skin, head and neck, colon, and prostate. In this review we present scientific evidence supporting the cancer stem cell model of tumor progression, and discuss the experimental and therapeutic implications. The concept of cancer stem cells may have profound implications for our understanding of tumor biology and for the design of novel treatments targeted toward these cells. Current therapeutic strategies include targeting the cancer stem cell as well as its microenvironmental niche. We present an interesting, novel strategy that takes into account the reactive oxygen species status in cancer stem cells and how it might serve as a method for eradicating these cells in tumor growth.
Similar articles
-
[Therapeutic Implication Targeting for Cancer Stem Cells].Gan To Kagaku Ryoho. 2015 Sep;42(9):1036-9. Gan To Kagaku Ryoho. 2015. PMID: 26469158 Japanese.
-
Stem cells, melanoma and cancer stem cells: the good, the bad and the evil?G Ital Dermatol Venereol. 2009 Jun;144(3):287-96. Epub 2008 Dec 17. G Ital Dermatol Venereol. 2009. PMID: 19088701 Review.
-
Current status and issues in cancer stem cell study.Cancer Invest. 2008 Aug;26(7):741-55. doi: 10.1080/07357900801901856. Cancer Invest. 2008. PMID: 18608212 Review.
-
Selective targeting of cancer stem cells: a new concept in cancer therapeutics.BioDrugs. 2007;21(5):299-310. doi: 10.2165/00063030-200721050-00002. BioDrugs. 2007. PMID: 17896836 Review.
-
Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.Cancer Treat Rep. 1986 Jan;70(1):183-99. Cancer Treat Rep. 1986. PMID: 3510734 Review.
Cited by
-
Targeting the PI3K-Akt-mTOR signaling pathway involved in vasculogenic mimicry promoted by cancer stem cells.Am J Cancer Res. 2023 Nov 15;13(11):5039-5046. eCollection 2023. Am J Cancer Res. 2023. PMID: 38058805 Free PMC article. Review.
-
Fatty Acid Metabolites and the Tumor Microenvironment as Potent Regulators of Cancer Stem Cell Signaling.Metabolites. 2023 May 31;13(6):709. doi: 10.3390/metabo13060709. Metabolites. 2023. PMID: 37367867 Free PMC article. Review.
-
Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance.Stem Cell Rev Rep. 2023 Aug;19(6):1577-1595. doi: 10.1007/s12015-023-10529-x. Epub 2023 May 2. Stem Cell Rev Rep. 2023. PMID: 37129728 Review.
-
Combination effect of cold atmospheric plasma with green synthesized zero-valent iron nanoparticles in the treatment of melanoma cancer model.PLoS One. 2022 Dec 19;17(12):e0279120. doi: 10.1371/journal.pone.0279120. eCollection 2022. PLoS One. 2022. Retraction in: PLoS One. 2024 May 23;19(5):e0304502. doi: 10.1371/journal.pone.0304502. PMID: 36534669 Free PMC article. Retracted.
-
Ferroptosis: A New Road towards Cancer Management.Molecules. 2022 Mar 25;27(7):2129. doi: 10.3390/molecules27072129. Molecules. 2022. PMID: 35408533 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
